Article Listing - CIBA LAUNCHES NEW AREDIA FORMULATION

GENERIC VERSION OF MAXZIDE-25 APPROVED

25 May 1992

- Geneva Pharmaceutical has received the first generic approval of a version of Mylan's Maxzide-25 (triamterene and hydrochloro-thiazide) from the...

SPARFLOXACIN DEAL

25 May 1992

ASTHMA DEATHS FALL

Asthma-related deaths in New Zealand have fallen sharply following a warning in 1989 that severe asthma patients should...

THALASSEMIA DRUG STUDY

25 May 1992

- Researchers from the Hospital for Sick Children, Toronto, are to publish a favourable study for the thalassemia drug, L-1....

MYLAN'S GENERIC METHOTREXATE

25 May 1992

- Mylan Laboratories has received an approval from the US Food and Drug Administration to manufacture and market generic tablets...

CORTECS SETS UP IN THE USA

25 May 1992

UK company Cortecs has opened its operations in New Jersey in the USA, it has announced. The US office will...

YUGOSLAV COS "INTEGRATE"

25 May 1992

Farmakos, the only factory producing medical supplies in the Serbian province of Kosovo, has been adversely affected by ethnic Albanians...

JAPAN NHI PRICE CUTS AVERAGE 6.1%

25 May 1992

A study undertaken by the National Health Insurance Pricing Comm-ittee of the Federation of Pharm-ceutical Manufacturers Associations of Japan has...

Synthelabo's Product Portfolio

25 May 1992

*t Product Class...

BIOTEST ON EXPANSION COURSE

25 May 1992

The German manufacturer of hospital products for the treatment of blood diseases and blood analysis, Biotest AG, says that it...

"GLITTERING YEAR" FOR ANZAG

25 May 1992

Andreae-Noris Zahn (Anzag), the German drug wholesaling group, has reported a "glittering" 1991, but expects 1992 sales to be below...